Childhood Lymphoma: Radiotherapy

Radiation therapy or radiotherapy is the use of high-energy x-rays to kill cancer cells and shrink tumors. Radiation for lymphoma usually comes from a machine outside the body (external-beam radiation therapy). Radiation therapy given to the neck, chest, and/or lymph nodes under the arms is called radiation therapy to a mantle field. Radiation therapy given to the mantle field and to the lymph nodes in the upper abdomen, the spleen, and the lymph nodes in the pelvis is called total nodal irradiation. Radiation therapy may be used alone or in addition to chemotherapy. Radiation is most often used in early stage, localized disease.

Radiation may significantly impair growth of bones and soft tissue so it's use in lymphoma treatment should be thought out accordingly. Unfortunately female patients who received radiation therapy between the ages of 10 and 16 mighty have an increased risk of breast cancer later in life.

To determine when radiation therapy may be used (dependent on factors such as lymphoma stage and bulkiness) see the NCI data sheets listed under the Childhood Lymphoma Resources Page.

 

Sponsored Links

 

Related Articles

Childhood lymphoma

Childhood Hodgkin's Disease: Treatment

Childhood Hodgkin's Disease: Chemotherapy

Childhood Lymphoma: Resources

Bone Marrow and Stem Cell Information Page

Childhood Hodgkin's Disease: Diagnosis

Childhood Hodgkin's Disease: Introduction

Childhood Non-Hodgkin's Lymphoma: Treatment

Childhood Non-Hodgkin's Lymphoma: Chemotherapy

Childhood Lymphoma: Resources

Bone Marrow and Stem Cell Information Page

Childhood Non-Hodgkin's Lymphoma: Diagnosis

Childhood Non-Hodgkin's Lymphoma: Introduction

Resources

Detailed information on Radiotherapy / Radiation Therapy

Childhood Radiation Resources

Hodgkin (sic) Disease in Children: Radiation Therapy - ACS
Childhood Non-Hodgkin's Lymphoma Radiation Therapy - ACS
NCI: Radiotherapy and MedlinePlus: Radiotherapy
Guide: Radiation Therapy and You - NCI

Supportive Care

Information on Hair Loss & Head Coverings
Locks of Love - an organization providing real hair coverings for children with cancer

Radiotherapy


See the childhood lymphoma radiation page for more information

Clinical Trials

See the new page on Clinical Trials

Other pages you may want to visit:

The Lymphoma Information Network

Adult Hodgkin's Disease Information Pages

Books

Books on Lymphoma Treatment including radiotherapy

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap